A CT promoter element binding protein: Definition of a double-strand and a novel single-strand DNA binding motif

Department of Human Genetics, Roswell Park Cancer Institute, Buffalo, NY 14263.
Nucleic Acids Research (Impact Factor: 9.11). 02/1992; 20(1):111-6. DOI: 10.1093/nar/20.1.111
Source: DBLP


Numerous genes contain promoter elements that are nuclease hypersensitive. These elements frequently possess polypurine/polypyrimidine stretches and are usually associated with altered chromatin structure. We have previously isolated a clone that binds a class of CT-rich promoter elements. We have further characterized this clone, termed the nuclease-sensitive element protein-1, or NSEP-1. NSEP-1 binds both duplex CT elements and the CT-rich strand of these elements in a 'generic' sequence specific manner and has overlapping but distinct single-and double-strand DNA binding domains. The minimal peptide region sufficient for both duplex and single-strand DNA binding includes two regions rich in basic amino acids flanking an RNP-CS-1 like octapeptide motif. Deletion analysis shows that the single-strand DNA binding activity is mediated by the RNP-CS-1 like octapeptide motif and is the key peptide region necessary for single-strand binding. NSEP-1's affinity for CT rich promoter elements with strand asymmetry in addition to its double- and single-strand DNA binding properties suggests that it may be a member of a class of DNA binding proteins that modulate gene expression by their ability to recognize DNA with unusual secondary structure.

10 Reads
  • Source
    • "The BMP7-promoter does not contain a Y-box (or its reverse, a CCAAT-box). However, YB1 has previously been shown to also bind and regulate non-Y-box promoters such as the epidermal growth factor receptor and this transcription factor recognizes target sites other than the classic Y-box [Kolluri et al., 1992; To et al., 2007]. The chemokine CCL5 (RANTES) in monocytes/macrophages as well as the HGF-receptor MET in breast cancer and normal mammary epithelial cells are also transcriptionally regulated by YB1 despite of the absence of a classic Y-box [Finkbeiner et al., 2009; Raffetseder et al., 2009]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bone morphogenetic protein-7 (BMP7) is an endogenous antifibrogenic protein in the kidney which is down regulated in experimental chronic kidney diseases such as obstructive and diabetic nephropathy in parallel with progressively increasing TGFβ. In vitro studies were performed in Madin-Darby Canine Kidney (MDCK)-cells to identify transcriptional regulators of BMP7. Experiments with various BMP7 promoter fragments (465-4,267  bp) identify small proximal promoter segments that are transcriptionally activated by high glucose (3.2-fold) but down regulated by TGFβ (0.2-fold) compared to normal glucose. Protein binding to these DNA segments is increased by high glucose and decreased by TGFβ in a time-dependent, progressive manner. Analysis of BMP7 promoter-binding proteins with liquid chromatography/tandem mass spectrometry (LC/MS/MS) identifies seven unique, partially overlapping peptides, spanning 25% of the amino acid sequence of Y-box protein-1 (YB1). EMSA-Western blot combination experiments confirm that YB1 is a BMP7 promoter-binding protein. YB1 knock-down reduces transcriptional responses to high glucose and TGFβ by about one-half, respectively. In addition, high glucose induces but TGFβ reduces nuclear translocation of YB1 from the cytoplasm. These studies identify YB1 as a transcriptional activator of BMP7 and helps to explain the progressive decline in renal BMP7 in diabetic nephropathy and other kidney diseases.
    Journal of Cellular Biochemistry 04/2011; 112(4):1130-7. DOI:10.1002/jcb.23027 · 3.26 Impact Factor
  • Source
    • "No CCAAT motif can be identified in the vicinity of nucleotide Ϫ6 of AGT. YB1 has been shown to bind to single-stranded DNA (Bayarsaihan et al. 1996; Hasegawa et al. 1991; Kolluri et al. 1992; MacDonald et al. 1995; Mertens et al. 1997; Ohmori et al. 1996), mRNA (Evdokimova et al. 1995), and damaged DNA, suggesting pleiotropic effects on DNA repair, maintenance/regulation of chromatin architecture, and general mRNA packing (Wolffe 1993). The specificity of the interaction between YB1 and the G23 oligonucleotide was supported by the lack of binding to Oct-1 oligonucleotide, previously validated and used as negative control in gel shift assay experiments (Inoue et al. 1997). "
    [Show abstract] [Hide abstract]
    ABSTRACT: A significant association has been reported between a common variant in the angiotensinogen gene (AGT), allele T235, and essential hypertension. In subsequent work, it was found that another variant, the presence of an adenine instead of a guanine 6bp upstream from the initiation site of transcription, was in absolute linkage disequilibrium with T235. The nucleotide substitution at the -6 position affected the formation of DNA-protein complexes in gel mobility shift assays and the basal transcription of AGT in transactivation experiments. We have further examined the potential impact of this polymorphism on AGT promoter function. In ultraviolet cross-linking analysis. 150- and 75-kDa proteins bound to the AGT proximal promoter. The possible involvement of factors that bind to GC-rich domains, including Sp1, Sp3, and AP2, was not supported by gel mobility shift assays. Screening an expression library with a double-stranded DNA segment centered on -6 led to the isolation of cDNA clones encoding the YB1 protein. The specificity of the interaction of YB1 with the proximal promoter of AGT was verified by Southwestern blotting and gel mobility shift assays. In cotransfection experiments, YB1 reduced basal AGT promoter activity in a dose-dependent manner. Although these observations suggest a possible role for YB1 in modulating AGT expression, this function is likely to occur in the context of complex interactions involving other nuclear factors. The work illustrates the challenge of developing a molecular understanding of the relationship between common genetic variants and conditions that are only partly caused by them.
    Journal of Human Genetics 02/2002; 47(1):7-13. DOI:10.1007/s10038-002-8649-2 · 2.46 Impact Factor
  • Source
    • "The Y-box proteins show a preference for duplex DNA enriched with pyrimidines and purines on opposite strands (Ozer et al., 1990 ; Sakura et al., 1988), specifically sequences containing a reverse CCAAT box motif (Dorn et al., 1987 a, b). These proteins can also interact with postulated H-form (triplex) DNA structures (Kolluri et al., 1992), apurinic ssDNA motifs (Hasegawa et al., 1991 ; Lenz et al., 1990) and mRNA (Deschamps et al., 1992 ; Murray et al., 1992 ; Sommerville & Ladomery, 1996). Diverse functional roles have been attributed to the Y-box family ranging from prokaryotic cold shock responses to eukaryotic transcription factors, chromatin modification proteins, DNA repair proteins, translational repressors, and RNA packaging proteins (Wolffe, 1994). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Transcriptional regulation of the human immunodeficiency virus type 1 (HIV-1) genome is mediated by viral and cellular factors. TAR, an unusual RNA regulatory element with a stem-bulge-loop structure at the 5' ends of all nascent viral transcripts is critical for HIV-1 transcription. TAR is the target for Tat, a viral transcription factor encoded early in the HIV-1 life-cycle and essential for gene expression. Evidence demonstrating the interaction of a cellular ssDNA/RNA binding protein, YB-1, with TAR through a region which is important for Tat interaction is presented. Interestingly, results from protein-protein interaction studies revealed that YB-1 can also form a complex with Tat. Results from mapping experiments suggest that while the region spanning aa 125-203 within YB-1 is essential for its association with TAR, a truncated YB-1 spanning aa 1-125 can weakly bind to Tat. Functionally, overexpression of full-length YB-1 enhanced Tat-induced activation of the HIV-1 minimal promoter containing TAR sequences, whereas mutant YB- 1 with no ability to bind to Tat and TAR failed to affect Tat-mediated activation. Expression of mutant YB-1(1-125), which binds to Tat but not RNA, decreased Tat-mediated enhancement of virus transcription. These observations suggest that while full-length YB-1 may function as a facilitator and, by interaction with both Tat and TAR, increase the level of Tat:TAR association, mutant YB-1 with no TAR binding activity, by complexing with Tat, may prevent Tat interaction with TAR. The importance of these findings in light of the proposed mechanism of Tat function is discussed.
    Journal of General Virology 11/1999; 80 ( Pt 10)(Pt 10):2629-38. DOI:10.1099/0022-1317-80-10-2629 · 3.18 Impact Factor
Show more


10 Reads
Available from